SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicinePerspective Published on 2022-02-112022-10-30 Journal: MedComm [Category] COVID-19, [키워드] 3D models Arm artificial B.1.1.529 continuous variation coronavirus disease correlated COVID‐19 COVID‐19 infection Defense delta variant diagnose diagnostics Efficiency exhibited Health health systems high mortality Hospitalization in vitro Infection intelligence introduced mechanism mutated Mutation mutations nanomedicine natural immunity omicron pandemic Pathogenesis Perspective Precision precision medicine provided receptor‐binding domain recommendation reservoirs Respiratory Coronavirus SARS‐CoV‐2 SARS‐CoV‐2 mutations severity Spread Structure subtype System the spike protein Vaccines variant variants viral infection virus VOCs World Health Organization [DOI] 10.1002/mco2.119 PMC 바로가기 [Article Type] Perspective
Alcohol use disorder in the COVID‐19 era: Position paper of the Italian Society on Alcohol (SIA)Original Article Published on 2021-09-162023-07-01 Journal: Addiction biology [Category] SARS, [키워드] alcohol use disorder COVID‐19 infection Drug interactions infections Telemedicine [DOI] 10.1111/adb.13090 PMC 바로가기 [Article Type] Original Article
Pleural empyema associated with alveolar‐pleural fistulas in severe acute respiratory syndrome coronavirus 2Case Report Published on 2021-06-222022-11-01 Journal: Clinical Case Reports [Category] COVID-19, [키워드] acute respiratory syndrome alveolar‐pleural fistula approach coronavirus COVID‐19 COVID‐19 infection disease Empyema Patient postoperative prolonged air leaks stability surgery surgical treatment therapeutic Treatment Ventilation [DOI] 10.1002/ccr3.4262 PMC 바로가기 [Article Type] Case Report
A UK survey of nutritional care pathways for patients with COVID‐19 prior to and post‐hospital stayOriginal Research Published on 2021-05-122022-10-30 Journal: Journal of Human Nutrition and Dietetics [Category] COVID-19, MERS, SARS, [키워드] addressed Care Care pathway COVID‐19 COVID‐19 infection COVID‐19 infection develop Dietitian Dietitians discharge eligibility criteria evaluate examined help hospital Inclusion Infection involved management nutrition nutritional care outcome measure over pandemic pathway Pathways Patient positive question questionnaire reported response responses Result Symptom weight weight loss [DOI] 10.1111/jhn.12896 PMC 바로가기 [Article Type] Original Research
SARS‐CoV‐2‐specific serological and functional T cell immune responses during acute and early COVID‐19 convalescence in solid organ transplant patientsOriginal Article Published on 2021-04-122023-06-15 Journal: American journal of transplantation : official jou [Category] MERS, SARS, [키워드] Adaptive immunity basic (laboratory) research / science clinical research / practice COVID‐19 infection heart transplantation / cardiology infection and infectious agents kidney transplantation / nephrology liver transplantation / hepatology solid organ transplantation T cell biology [DOI] 10.1111/ajt.16570 PMC 바로가기 [Article Type] Original Article
Characteristics and mechanisms to control a COVID‐19 outbreak on a leukemia and stem cell transplantation unitOriginal Research Published on 2020-12-122022-10-31 Journal: Cancer Medicine [Category] COVID-19, MERS, SARS, [키워드] acute myeloid leukemia adhere Allogeneic Antibody test Antibody testing autologous Characteristics Chemotherapy Clinical course Contact COVID‐19 COVID‐19 infection COVID‐19 infection diagnosed feature health‐care facilities hygiene immunocompromised individuals Immunosuppressed implementation Incubation period Infection Intensive leukemia lymphoma management of disease control Mask measure Measures mechanism mild symptoms outbreak Outbreaks Patient patients PCR positive Prevent preventing infection risk Stem cell transplantation subsequent symptomatic tested treated were infected without symptoms [DOI] 10.1002/cam4.3612 PMC 바로가기 [Article Type] Original Research
A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?Original Article Published on 2020-10-202022-10-29 Journal: Pharmacology Research & Perspectives [Category] COVID-19, MERS, SARS, [키워드] ACEi ACEIs adjusted Admission Analysis analyzed Angiotensin receptor blockers angiotensin‐converting enzyme inhibitors approach ARB ARBs association blocker clinical outcomes conducted confounders coronavirus COVID‐19 COVID‐19 infection COVID‐19 infection death drug eligible English enzyme evaluated Evidence good quality Hospitalization ICU admission indicated inhibitor lower risk Patient provided receptor reported risk scale severe acute respiratory syndrome coronavirus 2 Severe infection Significant significantly stratified systematic review USA [DOI] 10.1002/prp2.666 PMC 바로가기 [Article Type] Original Article
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID‐19 and its pneumonic superinfection and complicating inflammation?Review Published on 2020-07-292022-10-29 Journal: Scandinavian journal of immunology [Category] Coronavirus, MERS, SARS, [키워드] active against Agaricus Bacteria Can complicate COVID‐19 COVID‐19 infection COVID‐19 infection different diseases Effect Grifola frondosa Hericium erinaceus IBD immunomodulatory IMPROVE in vitro in vivo Infection Inflammation inflammatory disorders mechanism medicinal mushrooms mice microbe parasite Patient pneumococcal pneumococcal infection Prophylactic Quality of life reduce Sepsis severe lung inflammation shown significantly survival Symptom therapeutic effect Treatment [DOI] 10.1111/sji.12937 PMC 바로가기 [Article Type] Review